Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure-Reference-Cited by-同舟云学术

Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure

Published:2004-03 Issue:5 Volume:93 Page:603-606
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Hognestad Aina,Dickstein Kenneth,Myhre Eivind,Snapinn Steven,Kjekshus John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease;Majumdar;J Gen Intern Med,1999

2. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease;Sueta;Am J Cardiol,1999

3. The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes;Fonarow;Rev Cardiovasc Med,2002

4. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure;Rauchhaus;Int J Cardiol,2000

5. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction;Dickstein;Am J Cardiol,1999

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of regular statin intake on the development of cardiovascular events in the acute period of COVID-19 and within three months after discharge from the infectious diseases hospital. Part 1. Analysis of patients with fatal outcome during hospitalization;Ural Medical Journal;2022-11-04

2. Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients;Medical Science Monitor;2020-08-18

3. Short-term use of statins as an adjuvant therapy in patients with idiopathic dilated cardiomyopathy;Advances in Human Biology;2018

4. Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies;Therapeutics and Clinical Risk Management;2016-06

5. Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials;Cardiovascular Drugs and Therapy;2016-01-18